With so many predictions and promises being made in this much-talked about area of pharma and medicine, Dr Nicola Davies questions whether we truly are entering 25 November 2016
Speculation is rife about what Donald Trump’s election win means for pharma and health care in the USA, but what of its potential impact on the industry in Euro 15 November 2016
Imagine a world where what today may be the most common and routine of operations are made all but impossible without a severe risk of death from infection.Wher 17 October 2016
The number of people dying from opioid or heroin overdoses has nearly quadrupled in the US since the beginning of century leading to increased scrutiny of laws 3 October 2016
When Mary Mitchell-O’Connor, Ireland’s Minister of Jobs, Enterprise and Innovation, was speaking at a Dublin conference last week, she could have used countless 26 September 2016
If asked to picture the average biopharma chief executive.chief financial officer or board member.the first image to come to mind for most people would undoubte 5 September 2016
Although the performance and procedural goals for the sixth iteration of the Prescription Drug User Fee Act (PDUFA) were laid out last month.pharmaceutical comp 30 August 2016
Much like a soccer player having to adapt his game when he goes to play in a different national league, pharma companies need a different approach to gaining re 15 August 2016
The pharmaceutical industry has started to embrace social media as a force for good with companies beginning to see its potential away from marketing and commun 8 August 2016
Some 5,000 Alzheimer's and Dementia researchers gathered in Toronto last week for the Alzheimer's Association International Conference (AAIC) 2016, where some i 1 August 2016
It is an indisputable fact that Brexit has sent shockwaves through the pharmaceutical and life science industries and although the exact extent of the fallout i 23 July 2016
Mergers and collaborations are more prominent than ever in pharma and biotech, with last year proving a record-breaker for the value of deals done. 19 July 2016
The pharmaceutical industry’s use of directors from outside the sector has fallen from 40% to 26% in the last five years, research from executive search firm DH 12 July 2016
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.